GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
2.150
-0.020 (-0.92%)
Mar 19, 2026, 4:00 PM EDT - Market closed
GoodRx Holdings Stock Forecast
Stock Price Forecast
The 9 analysts that cover GoodRx Holdings stock have a consensus rating of "Buy" and an average price target of $3.86, which forecasts a 79.53% increase in the stock price over the next year. The lowest target is $2.50 and the highest is $6.00.
Price Target: $3.86 (+79.53%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GoodRx Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 3 | 2 | 1 | 1 |
| Hold | 4 | 5 | 5 | 6 | 7 | 7 |
| Sell | 0 | 0 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 11 | 11 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $7 → $3.5 | Buy | Maintains | $7 → $3.5 | +62.79% | Mar 4, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $4.5 → $3.5 | Strong Buy | Maintains | $4.5 → $3.5 | +62.79% | Mar 3, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $4 → $2.5 | Hold | Maintains | $4 → $2.5 | +16.28% | Mar 2, 2026 |
| Mizuho | Mizuho | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +39.53% | Feb 27, 2026 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 27, 2026 |
Financial Forecast
Revenue This Year
780.06M
from 796.85M
Decreased by -2.11%
Revenue Next Year
822.05M
from 780.06M
Increased by 5.38%
EPS This Year
0.37
from 0.09
Increased by 329.76%
EPS Next Year
0.43
from 0.37
Increased by 17.41%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 813.1M | 871.9M | |||
| Avg | 780.1M | 822.1M | |||
| Low | 738.0M | 754.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.0% | 11.8% | |||
| Avg | -2.1% | 5.4% | |||
| Low | -7.4% | -3.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 0.53 | 0.61 | ||
| Avg | 0.37 | 0.43 | ||
| Low | 0.26 | 0.28 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 514.6% | 65.9% | ||
| Avg | 329.8% | 17.4% | ||
| Low | 209.7% | -22.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.